Speaking at the above panel is Dr Kezhou Zhang, Vice President, Medical Director, Novo Nordisk (China) Pharmaceuticals, China. He will be speaking at Pharma Trials World Asia 2012, part of a series of conferences at the 5th Annual BioPharma Asia Convention 2012.
Dr. Zhang is the Vice President of medical affairs, clinical development and regulatory affairs for the great China region of Novo Nordisk, he has more than 10 years experience in R&D and commercial function of pharmaceutical industry. Prior to the current position located in China, Dr. Zhang had worked at Novo Nordisk's headquarters in Denmark for 6 years. He holds MD, PhD and MBA degrees.
Panel: Optimising clinical trials in Asian powerhouses – India & China
1. Overcoming regulatory constraints in the two largest Asian markets to fast-track clinical trials
2. Aligning clinical development, medical affairs and regulatory affairs to enhance your clinical trial design
3. Determining key factors for a successful partnership between pharmas, biotechs and CROs